Frankfurt
15.10.26 | 15:25
0,112 Euro
-3,45 % -0,004
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.09. | Dividendenbekanntmachungen (25.09.2026) | 7.485 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADF GROUP INC CA00089N1033 0,02 CAD 0,0124 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,22 USD 0,1933 EUR ASMODEE GROUP AB SE0023615638 - 0... ► Artikel lesen | |
| 23.09. | LEE'S PHARM (00950): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT | 2 | HKEx | ||
| 23.09. | LEE'S PHARM (00950): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT | 1 | HKEx | ||
| 23.09. | LEE'S PHARM (00950): INTERIM REPORT 2026 | 2 | HKEx | ||
| 09.09. | 1cBio, Lee's Pharm Ink License Agreement for PARP1 Inhibitor in China, Southeast Asia | 1 | Contract Pharma | ||
| 09.09. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE ON THE LICENSING AGREEMENT IN RELATION TO THE DEVELOPMENT, MANUFACTURE AND COMMERCIALISATION ... | 3 | HKEx | ||
| 31.08. | Lee's Pharmaceutical Holdings Ltd. Bottom Line Advances In H1 | 2 | RTTNews | ||
| 31.08. | LEE'S PHARM (00950): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2026 | 1 | HKEx | ||
| LEES PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| 31.08. | LEE'S PHARM (00950): INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026 | 1 | HKEx | ||
| 26.08. | LEE'S PHARM (00950): POSITIVE PROFIT ALERT | 1 | HKEx | ||
| 18.08. | LEE'S PHARM (00950): NOTICE OF BOARD MEETING | - | HKEx | ||
| 30.07. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG APPLICATION IN CHINA FOR PROPRIETARY ADC PROJECT ZK2401 ACCEPTED BY NMPA | 3 | HKEx | ||
| 21.07. | Ashlins schließt Lizenzabkommen mit Lee's Pharm für Interferon-Wirkstoff | 11 | Investing.com Deutsch | ||
| 17.07. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - ENTERING INTO EXCLUSIVE LICENSE-OUT AND SUPPLY AGREEMENT WITH ASHLINS FOR INTERFERON ALPHA-2B PRODUCTS ... | 1 | HKEx | ||
| 16.06. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE PROGRAM UNDER THE REPURCHASE MANDATE | 1 | HKEx | ||
| 01.06. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - FUNDING APPROVED FOR SYNTHETIC SURFACTANT PROJECT | 1 | HKEx | ||
| 27.05. | Dividendenbekanntmachungen (27.05.2026) | 9.096 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAC TECHNOLOGIES HOLDINGS INC ADR US0003041052 0,0446 USD 0,0384 EUR ADVANCE TERRAFUND REIT BG1100025052 - 0,065 EUR APOTEA AB SE0023313762 0... ► Artikel lesen | |
| 21.05. | LEE'S PHARM (00950): ANNUAL GENERAL MEETING HELD ON 21 MAY 2026 - POLL RESULTS | 1 | HKEx | ||
| 11.05. | LEE'S PHARM (00950): CONNECTED TRANSACTION - INVESTMENT IN PARTNERSHIP FUND | 1 | HKEx | ||
| 24.04. | LEE'S PHARM (00950): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 141,36 | +2,67 % | Gilead and Vir forge $1.9bn pact to develop next-gen T-cell engagers | ||
| ZOETIS | 70,48 | +4,35 % | Zoetis holt Iris Knobloch - was Anleger wissen müssen | ||
| SINOPHARM | 1,796 | +1,15 % | Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed... ► Artikel lesen | |
| CSPC PHARMA | 1,025 | +3,34 % | CSPC PHARMA SYS 6088 Injection Approved for Clinical Trials in China | ||
| WUXI BIOLOGICS | 5,540 | -1,25 % | WuXi Biologics Passes Another FDA GMP Inspection, Reinforcing Its Quality Track Record and Commercial Supply Reliability | WUXI, China, Sept. 24, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,926 | -1,21 % | FOSUN PHARMA (02196): DATE OF BOARD MEETING | ||
| GEDEON RICHTER | 34,880 | +2,65 % | Gedeon Richter Plc.: Transactions with Treasury Shares | ||
| DR REDDYS | 11,400 | 0,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| MEDIPHARM LABS | 0,041 | -4,71 % | Medipharm Labs Corp: Medipharm Labs ships CBD inhalers to Panama in first sale | ||
| ASPEN PHARMACARE | 8,300 | +3,11 % | ASPEN PHARMACARE HOLDINGS LIMITED - No Change Statement, Availability of Audited Annual Financial Statements and Notice of Annual General Meeting | ||
| SHANGHAI PHARMACEUTICALS | 1,250 | 0,00 % | SH PHARMA Clevidipine Injectable Emulsion Approved for Production | ||
| LUYE PHARMA | 0,189 | 0,00 % | LUYE PHARMA (02186): INTERIM REPORT 2026 | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,079 | -1,88 % | SIHUAN PHARM Makes Strategic Investment in Hanteng Biotech, Plans Commercialization Cooperation | ||
| HANSOH PHARMACEUTICAL | 3,518 | +1,21 % | Tortugas' schizophrenia drug proves worth in phase 2 Hansoh trial in China | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,520 | -1,89 % | CHINARES PHARMA 's DC7001A Capsules Approved by US FDA for Clinical Trials |
LEES PHARMACEUTICAL HOLDINGS LTD gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 0,112 Euro und damit -3,45 % im Minus. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LEES PHARMACEUTICAL HOLDINGS LTD finden Sie auf Wallstreet Online.